CMI
NVO

Clare Market Investments’s Novo Nordisk NVO Stock Holding History

Clare Market Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,035
Closed -$1.59M – 164
2025
Q2 		$1.59M Buy
23,035
+12,287
+114% +$836K 0.35% 40
2025
Q1 		$746K Sell
10,748
-3,782
-26% -$312K 0.2% 64
2024
Q4 		$1.25M Buy
14,530
+7,091
+95% +$767K 0.3% 45
2024
Q3 		$886K Buy
7,439
+2,054
+38% +$274K 0.23% 58
2024
Q2 		$769K Buy
5,385
+1,528
+40% +$202K 0.21% 60
2024
Q1 		$495K Buy
3,857
+237
+7% +$28.2K 0.15% 92
2023
Q4 		$374K Buy
+3,620
New +$358K 0.13% 100

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Clare Market Investments's NVO Position: Q3 2025 in Review

Clare Market Investments sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 23,035 shares — an estimated $1.59M sold.

Clare Market Investments first reported a position in NVO in Q4 2023 and held it in 7 quarters. The position peaked at $1.59M in Q2 2025. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Clare Market Investments reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Clare Market Investments sold 23,035 Novo Nordisk shares in Q3 2025, an estimated $1.59M.
  • Clare Market Investments first reported a position in Novo Nordisk in Q4 2023 and held it in 7 quarters.
  • Clare Market Investments's Novo Nordisk position peaked at $1.59M in Q2 2025.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Clare Market Investments's 13F filing for Q3 2025, filed 12 Nov 2025.